Susquehanna International Group
ANAB icon

Susquehanna International Group’s AnaptysBio ANAB Stock Holding History

Susquehanna International Group’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$299K Sell
5,400
-299,100
-98% -$16.1M ﹤0.01% 10860
2025
Q4 		$14.8M Buy
304,500
+92,800
+44% +$3.62M ﹤0.01% 2557
2025
Q3 		$6.48M Buy
211,700
+114,600
+118% +$2.63M ﹤0.01% 3682
2025
Q2 		$2.16M Sell
97,100
-40,000
-29% -$837K ﹤0.01% 5635
2025
Q1 		$2.55M Sell
137,100
-216,200
-61% -$3.61M ﹤0.01% 4999
2024
Q4 		$4.68M Buy
353,300
+241,400
+216% +$5.85M ﹤0.01% 3698
2024
Q3 		$3.75M Buy
+111,900
New +$3.82M ﹤0.01% 4127
2023
Q2 		– Sell
-31,200
Closed -$679K – 11992
2023
Q1 		$679K Sell
31,200
-2,800
-8% -$68K ﹤0.01% 7803
2022
Q4 		$1.05M Buy
+34,000
New +$960K ﹤0.01% 6070
2022
Q3 		– Sell
-10,100
Closed -$205K – 13101
2022
Q2 		$205K Buy
+10,100
New +$224K ﹤0.01% 10562
2021
Q4 		– Sell
-10,100
Closed -$274K – 13053
2021
Q3 		$274K Sell
10,100
-14,300
-59% -$363K ﹤0.01% 10792
2021
Q2 		$633K Sell
24,400
-104,100
-81% -$2.5M ﹤0.01% 8988
2021
Q1 		$2.77M Buy
+128,500
New +$3.24M ﹤0.01% 5146
2020
Q4 		– Sell
-10,200
Closed -$150K – 10967
2020
Q3 		$150K Sell
10,200
-1,900
-16% -$34.3K ﹤0.01% 9681
2020
Q2 		$270K Sell
12,100
-30,000
-71% -$548K ﹤0.01% 8534
2020
Q1 		$595K Sell
42,100
-55,500
-57% -$842K ﹤0.01% 6545
2019
Q4 		$1.59M Sell
97,600
-126,600
-56% -$2.99M ﹤0.01% 4697
2019
Q3 		$7.84M Buy
224,200
+116,700
+109% +$5.55M ﹤0.01% 2226
2019
Q2 		$6.07M Buy
107,500
+34,500
+47% +$2.48M ﹤0.01% 2463
2019
Q1 		$5.33M Sell
73,000
-12,600
-15% -$870K ﹤0.01% 2367
2018
Q4 		$5.46M Buy
85,600
+9,500
+12% +$706K ﹤0.01% 2183
2018
Q3 		$7.59M Buy
76,100
+2,600
+4% +$216K ﹤0.01% 2200
2018
Q2 		$5.22M Sell
73,500
-310,200
-81% -$26M ﹤0.01% 2654
2018
Q1 		$39.9M Buy
383,700
+246,800
+180% +$27.8M 0.01% 773
2017
Q4 		$13.8M Buy
+136,900
New +$10.1M ﹤0.01% 1550

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Susquehanna International Group's ANAB Position: Q1 2026 in Review

Susquehanna International Group opened a new position in AnaptysBio (ANAB) in Q1 2026: 26,577 shares worth $1.47M. The stake represents ﹤0.01% of the portfolio and ranks #6926 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in ANAB as recently as Q3 2025.

Susquehanna International Group first reported a position in ANAB in Q4 2017 and has held it in 30 quarters since. The position peaked at $8.88M in Q1 2018. 207 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.

  • Susquehanna International Group held 26,577 shares of AnaptysBio worth $1.47M as of Q1 2026.
  • AnaptysBio was a new Susquehanna International Group position in Q1 2026.
  • AnaptysBio made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6926 holding.
  • Susquehanna International Group first reported a position in AnaptysBio in Q4 2017 and has held it in 30 quarters since.
  • Susquehanna International Group's AnaptysBio position peaked at $8.88M in Q1 2018.
  • 207 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.